1. Home
  2. YEXT vs RCUS Comparison

YEXT vs RCUS Comparison

Compare YEXT & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

HOLD

Current Price

$8.34

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$21.61

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YEXT
RCUS
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
3.1B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
YEXT
RCUS
Price
$8.34
$21.61
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$9.44
$29.38
AVG Volume (30 Days)
937.1K
2.0M
Earning Date
12-08-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$447,666,000.00
$240,000,000.00
Revenue This Year
$8.92
N/A
Revenue Next Year
$5.14
N/A
P/E Ratio
$14,257.68
N/A
Revenue Growth
9.46
N/A
52 Week Low
$5.51
$6.50
52 Week High
$9.20
$26.40

Technical Indicators

Market Signals
Indicator
YEXT
RCUS
Relative Strength Index (RSI) 42.50 43.57
Support Level $8.07 $24.75
Resistance Level $8.62 $26.10
Average True Range (ATR) 0.22 1.50
MACD -0.02 -0.41
Stochastic Oscillator 28.13 21.97

Price Performance

Historical Comparison
YEXT
RCUS

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: